It was into up cycle since the AGM. The yearly MA became good support.
broker, MB
Action and recommendation
• Upgrade to Outperform (from Neutral).
Earnings and target price revision
• FY21/22/2 EPS n.m./+24%/+14% driven by cost benefits/ op leverage. PT
upgraded to $20.00 (from $15.30), reflecting earnings changes & reduced
risk discount in FY24 (by 1/3) with vaccine rollout now underway.
Up cycle now
Add FLT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.23 |
Change
0.240(1.14%) |
Mkt cap ! $4.685B | |||
| Open | High | Low | Value | Volume |
| $21.10 | $21.32 | $21.05 | $7.831M | 369.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 2491 | $21.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.24 | 1213 | 13 |
View Market Depth
| Last trade - 14.40pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$21.19 |
Change
0.240 ( 0.84 %) |
||||
| Open | High | Low | Volume | ||
| $21.08 | $21.31 | $21.06 | 960688 | ||
| Last updated 14.58pm 29/04/2024 ? | |||||
| FLT (ASX) Chart |